These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 772196)
1. Aspirin, platelets and myocardial infarction--proposal for a trial. Williams WO; Elwood PC J R Coll Gen Pract; 1975 Nov; 25(160):844. PubMed ID: 772196 [No Abstract] [Full Text] [Related]
2. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery. Cairns JA Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983 [No Abstract] [Full Text] [Related]
3. Can aspirin prevent myocardial infarction? Med Lett Drugs Ther; 1975 Mar; 17(6):25-6. PubMed ID: 1092992 [No Abstract] [Full Text] [Related]
4. Role of platelet-active drugs in coronary artery disease. Sherry S Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025 [No Abstract] [Full Text] [Related]
5. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease. Genton E Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166 [No Abstract] [Full Text] [Related]
6. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease. Passamani ER Circulation; 1980 Dec; 62(6 Pt 2):V106-10. PubMed ID: 7002348 [TBL] [Abstract][Full Text] [Related]
7. Cardiac death prevention in post-myocardial infarction patients: a review. Boissel JP; Leizorovicz A; Faucomprez C Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625 [No Abstract] [Full Text] [Related]
8. Controversies in cardiology. Proposed: low-dose aspirin should be taken daily after age 40 if total serum cholesterol is greater than 160. Schoenberger JA; Mann GV Hosp Pract (Off Ed); 1982 Dec; 17(12):50A, 50D, 50F passim. PubMed ID: 6815063 [No Abstract] [Full Text] [Related]
9. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features. Furberg CD; May GS Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352 [TBL] [Abstract][Full Text] [Related]
10. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes. Sherry S Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782 [No Abstract] [Full Text] [Related]
11. Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review. Bélanger GL; Lavallée JP; Lenis J; Ouellet CA Can J Cardiol; 1985 Mar; 1(2):97-105. PubMed ID: 2864991 [TBL] [Abstract][Full Text] [Related]
12. Proceedings: A clinical trial of antiplatelet therapy in patients with coronary arterial disease. Michaels L; Galbraith PA; Ledwich JR Thromb Diath Haemorrh; 1975 Nov; 34(2):598-9. PubMed ID: 1105881 [No Abstract] [Full Text] [Related]
13. Usefulness of aspirin for coronary artery disease. Fuster V; Cohen M; Chesebro JH Am J Cardiol; 1988 Mar; 61(8):637-40. PubMed ID: 3278582 [No Abstract] [Full Text] [Related]
15. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction]. Vyshlov EV; Panfilova EV; Markov VA Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373 [TBL] [Abstract][Full Text] [Related]
16. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]